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Cytochromes P450 (CYP) are a superfamily of enzymes,
involved in metabolism of xenobiotic compounds. CYP
are involved in metabolism of a large amount of drugs,
currently present on the market. Therefore, prediction of
CYP inhibition activity of small molecules poses an impor-
tant task, especially in early stage drug discovery, due to
high risk of drug-drug interactions. It is estimated that
CYP enzymes metabolize over 75% of currently marketed
drugs. Of these reactions over 90% are facilitated by
CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4. This
makes these enzymes particularly interesting targets for
in-silico inhibition prediction. Accurate prediction of inhi-
bition activity of small molecules against CYP enzymes is
particularly important in the field of personalized medicine
discovery.
High promiscuity with respect to substrates of the stu-
died cytochromes limits the approach of traditional QSAR
methods. Including structural information of the protein is
crucial to obtaining predictive models. In this work the
modeling is performed on a set of chemogenomic descrip-
tors obtained from protein-ligand complexes. The quality
of the descriptors is benchmarked in QSAR modeling of
HTS data for human CYP450 inhibition. The calculation
of descriptors involves a flexible docking of the molecule
to the rigid binding cite of the cytochrome (in this study
the AutoDock Vina tool was used). The obtained top-
ranked conformation is then processed to obtain the
descriptors.
The training sets for the benchmarked models were
obtained from PubChem BioAssay database (assays
AID410, AID883, AID899, AID884 and AID891 for
CYP1A2, 2C9, 2C19, 3A4 and 2D6, respectively). The test
sets are obtained from the AID1851 assay by excluding all
molecules present in the training set.
The models presented in the study achieved 82 - 87% of
correctly classified compounds on the validated training
set and 65 - 75% of correctly classified instances on the
test sets. The dramatic difference in model performance
between the test and the validated training sets can be
explained by structural dissimilarity of the sets.
The use of applicability domain approaches to select
only confident predictions allowed to achieve the accuracy
of 90% of correctly classified instances on the subset of
20% most confident predictions of the test set.
The datasets and the benchmarked models are available
on the Online Chemical Modeling Environment (http://
ochem.eu).
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